Kauris-CTS 750 Injection
Marketer
Kauris Care Private Limited
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Kauris-CTS 750 Injection
Kauris-CTS 750 Injection, a multi-component medication, combats diverse bacterial infections. Its action inhibits microbial proliferation, curbing infection spread. Administration must be solely by a healthcare provider. Adherence to the prescribed treatment schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and indigestion are possible side effects; worsening symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Disclose all current medications to your physician before use. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability isn't typically affected, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, nutritious food, and sufficient hydration promote faster recovery. Your doctor may order blood tests and other diagnostics to monitor the medication's effects.
Primary Ingredients of Kauris-CTS 750 Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Kauris-CTS 750 Injection
Infections caused by bacteria
Major Benefits of Kauris-CTS 750 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Kauris-CTS 750 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kauris-CTS 750 Injection:
Administering this medication will be done by your physician or their qualified nurse; self-medication is strongly discouraged.
How Kauris-CTS 750 Injection works:
Ceftriaxone and Sulbactam, the active components of Kauris-CTS 750 Injection, work synergistically to combat bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to multiply. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Kauris-CTS 750 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injection Kauris-CTS 750 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nonetheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
The administration of Kauris-CTS 750 Injection to breastfeeding mothers requires careful consideration. It's recommended to discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Kauris-CTS 750 Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Kauris-CTS 750 Injection's use in individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Kauris-CTS 750 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Kauris-CTS 750 Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Kauris-CTS 750 Injection :
Omitting a scheduled dose of Kauris-CTS 750 Injection necessitates contacting your physician.
Facts to Know About Kauris-CTS 750 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently